12:01 PM EDT, 06/18/2024 (MT Newswires) -- Shuttle Pharmaceuticals Holdings ( SHPH ) said Tuesday it has appointed Timothy Lorber as chief financial officer, succeeding Michael Vander Hoek, who will assume the role of vice president of regulatory on a full-time basis.

Lorber will initially serve as part-time CFO through Sept. 9, and become full-time CFO starting Sept. 10, the company said.

Lorber more recently served in leadership roles with several privately held businesses, Shuttle Pharmaceuticals ( SHPH ) said.